help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Calvo, R. M.
Right arrow Articles by Escobar-Morreale, H. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Calvo, R. M.
Right arrow Articles by Escobar-Morreale, H. F.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 4 1746-1749
Copyright © 2001 by The Endocrine Society


Original Studies

Screening for Mutations in the Steroidogenic Acute Regulatory Protein and Steroidogenic Factor-1 Genes, and in CYP11A and Dosage-Sensitive Sex Reversal-Adrenal Hypoplasia Gene on the X Chromosome, Gene-1 (DAX-1), in Hyperandrogenic Hirsute Women1

Rosa M. Calvo2, Miryam Asunción2, Dolores Tellería, José Sancho, José L. San Millán and Héctor F. Escobar-Morreale

Departments of Endocrinology (R.M.C., M.A., J.S., H.F.E.-M.) and Molecular Genetics (D.T., J.L.S.M.), Hospital Ramón y Cajal, Madrid 28034, Spain

Address all correspondence and requests for reprints to: Héctor F. Escobar-Morreale, M.D., Ph.D., Department of Endocrinology, Hospital Ramón y Cajal, Carretera de Colmenar Km 9'100, 28034 Madrid, Spain. E-mail: hector.escobar{at}uam.es

Abstract

Abnormalities in adrenal and/or ovarian steroidogenesis are found in most patients with hirsutism. The rate-limiting step in the synthesis of steroids in the ovary and the adrenal is the conversion of cholesterol into pregnenolone by cholesterol side-chain cleavage enzyme (P450scc), encoded by the gene CYP11A, after cholesterol is introduced into the mitochondria by the steroidogenic acute regulatory protein (StAR). DAX-1 is a repressor of StAR gene expression, and steroidogenic factor-1 (SF-1) is a regulator of CYP11A, DAX-1, and StAR gene. Mutations in any of these factors resulting in gain of function, or loss of repression, of StAR or P450scc might contribute to the steroidogenic abnormalities present in hirsute patients.

In the present study we have screened, using heteroduplex analysis, the genes encoding StAR and SF-1 as well as DAX-1 and CYP11A for mutations in genomic DNA from 19 women presenting with hirsutism and increased serum androgen levels. When variants were found, analysis was extended to a larger group of hyperandrogenic patients and nonaffected women. Two variants were identified in the SF-1 gene. A G->C change in exon 6, resulting in an Arg365Pro mutation, was found in 1 of 45 patients, but not in controls. Also, a Gly146Ala missense mutation, resulting from a G->C change in exon 4, was found in 2 of 48 patients and in 2 of 50 nonaffected individuals. We identified a C->T base pair change at position -33 of the StAR gene. Three of 48 patients and 3 of 43 controls presented this variant. No mutations were found in coding regions of the StAR gene. Analysis of CYP11A-coding regions identified a G->A change in exon 3, resulting in a Val179Ile missense mutation. This mutation was found in 1 of 29 patients studied and was not present in 50 controls. Finally, analysis of DAX-1 showed no variant in any of the women studied.

In conclusion, mutations in StAR, SF-1, CYP11A, and DAX-1 are seldom found in hirsute patients and do not explain the steroidogenic abnormalities found in these women.




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
I. A. Pikuleva
CHOLESTEROL-METABOLIZING CYTOCHROMES P450
Drug Metab. Dispos., April 1, 2006; 34(4): 513 - 520.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
H. F. Escobar-Morreale, M. Luque-Ramirez, and J. L. San Millan
The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome
Endocr. Rev., April 1, 2005; 26(2): 251 - 282.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
W. Zheng, Y.-T. Gao, X.-O. Shu, W. Wen, Q. Cai, Q. Dai, and J. R. Smith
Population-Based Case-Control Study of CYP11A Gene Polymorphism and Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 709 - 714.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Peral, J. L. San Millan, R. Castello, P. Moghetti, and H. F. Escobar-Morreale
The Methionine 196 Arginine Polymorphism in Exon 6 of the TNF Receptor 2 Gene (TNFRSF1B) Is Associated with the Polycystic Ovary Syndrome and Hyperandrogenism
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3977 - 3983.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society